Scientists have developed a new tissue ‘scaffold’ technology that could one day enable the engineering of large organs
Research led by the Universities of Bristol and Liverpool has shown that it is possible to combine cells with a special scaffold to produce living tissue in the laboratory. It is hoped this can then be implanted into patients as a way of replacing diseased parts of the body.
Until now, the approach has generally been limited to growing small pieces of tissue, as larger dimensions reduce the oxygen supply to the cells in the centre.
A team of researchers, led by Dr Adam Perriman from the University of Bristol and Professor Anthony Hollander from the University of Liverpool, used cartilage tissue engineering as a model system for testing a new method of overcoming the oxygen limitation problem.
They synthesised a new class of artificial membrane binding proteins that can be attached to stems cells. By attaching an oxygen-carrying protein, myoglobin, to the stem cells before they are used to engineer cartilage, they ensure that each cell has its own oxygen reservoir that it can access when the oxygen in the scaffold drops to dangerously low levels.
Dr Perriman from Bristol’s School of Cellular and Molecular Medicine said: “From our preliminary experiments, we found that we could produce these artificial membrane binding proteins and paint the cells without affecting their biological function.
“However, we were surprised and delighted to discover that we could deliver the necessary quantity to the cells to supplement their oxygen requirements. It’s like supplying each cell with its own scuba tank, which it can use to breathe from when there is not enough oxygen in the local environment.”
The team’s findings, published today [17 June] in Nature Communications, could really expand the possibilities in tissue engineering, not only in cartilage, but also for other tissue such as cardiac muscle or bone.
Professor Hollander said: “We have already shown that stem cells can help create parts of the body that can be successfully transplanted into patients, but we have now found a way of making their success even better.
“Growing large organs remains a huge challenge but with this technology we have overcome one of the major hurdles.
“Creating larger pieces of cartilage gives us a possible way of repairing some of the worst damage to human joint tissue, such as the debilitating changes seen in hip or knee osteoarthritis or the severe injuries caused by major trauma, for example in road traffic accidents or war injuries.”
Their new methodology, describing the conversion of a normal protein into a membrane binding protein, is likely to pave the way for the development of a wide range of new biotechnologies.
The Latest on: Tissue scaffold technology
via Google News
The Latest on: Tissue scaffold technology
- A standalone bioreactor system to deliver compressive load under perfusion flow to hBMSC-seeded 3D chitosan-graphene templateson November 14, 2019 at 3:17 am
These observations show that our novel device could be a potentially valuable a technology for addressing and ... USA) in sterile tissue culture–grade phosphate-buffered saline (PBS) was administered ...
- Human clinical trials for technology aiming to improve the quality of life after breast reconstruction to begin later this yearon November 14, 2019 at 2:36 am
Evonik, a specialist in biomaterials for implantable medical devices has signed an agreement for the use of a Resomer bioresorbable polymer for innovative breast implant technology with BellaSeno ...
- Evonik partners with 3D-printed breast implant startupon November 12, 2019 at 12:50 pm
The Senella breast scaffold product, which is designed to be implanted after breast reconstruction, augmentation or revision surgery, progressively resorbs as it is replaced by the formation of ...
- Generation of a Comprehensive Transcriptome Atlas and Transcriptome Dynamics in Medicinal Cannabison November 12, 2019 at 2:09 am
Full size table The initially assembled scaffolds (57,268 ... generated using RNA-Seq technology. By extensive sampling of various vegetative and reproductive tissue types, a transcriptome atlas of ...
- Evonik and BellaSeno partner to enable the launch of an innovative 3D printed breast implant technologyon November 11, 2019 at 4:00 pm
Degradation of RESOMER® to match the growth of the patient's own tissue for natural breasts - Technology designed ... the use of a RESOMER® bioresorbable polymer for an innovative breast implant ...
- Interview with Riddhi Maharaj on 3D Printing Space Systems in Africaon November 10, 2019 at 12:04 am
Making use of our 30 plus years of experience in the space industry, our team specializes in high-reliability Attitude Control Systems and services such as contract manufacturing and technology ...
- Beijing University of Chemical Technology: 3D Printed HA/PCL Tissue Engineering Scaffoldson November 8, 2019 at 11:11 pm
Using hydroxyapatite (HA) and polycaprolactone (PCL) as raw materials, nano-HA/PCL and micro-HA/PCL that composite with 20 wt% HA were prepared by melt blending technology, and HA/PCL composite tissue ...
- Hope for Resorbable Vascular Scaffolds in Peripheral Disease Below the Knee?on November 6, 2019 at 1:31 pm
There were no reports of late or very late scaffold thrombosis, which Varcoe said gives him “great reassurance.” Furthermore, 90% of patients treated for tissue loss had complete wound healing and ...
- Olathe startup's goal: Mass produce stem cells that help grow organson November 6, 2019 at 11:37 am
Through their startup Ronawk LLC, the team developed Tissue Block, or T-Block, a technology with the ability to quickly mass produce patient ... Made from the same hydrogel material used in Jell-O and ...
- Shape Memory Medical Wins 2019 R&D 100 Award for Its Novel Impede® Embolization Deviceon November 5, 2019 at 4:05 pm
The porous scaffold is a biocompatible tissue scaffold that promotes rapid conversion to organized thrombus ... “The R&D 100 Award is well-deserved recognition of the ongoing basic science supporting ...
via Bing News